Market Insights Health OTC Pharmaceuticals

Cold & Cough Remedies - France

France

In France, the revenue in the Cold & Cough Remedies market market reached €0.65bn in 2024.
It is projected that the market will experience an annual growth rate of 4.24% (CAGR 2024-2029).
When compared to other countries worldwide, the in the United States generates the highest revenue in this market, amounting to €10,270.00m in 2024.
Looking at the per person figures, in 2024, the revenue generated per individual is €9.98.
France's cold and cough remedies market is being driven by a growing demand for natural and herbal products.

Key regions: Australia, Japan, India, Brazil, Canada

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Cold & Cough Remedies market in France is experiencing steady growth and development.

Customer preferences: In France, customers have a strong preference for natural and herbal remedies when it comes to treating cold and cough symptoms. They are increasingly seeking products that are free from artificial ingredients and chemicals. This preference for natural remedies is driven by a growing awareness of the potential side effects of conventional medications and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for cold and cough remedies that are made from natural ingredients such as herbs, essential oils, and plant extracts.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in France is the increasing popularity of homeopathic remedies. Homeopathy is a system of alternative medicine that uses highly diluted substances to stimulate the body's natural healing processes. Homeopathic cold and cough remedies have gained traction in France due to their perceived safety and efficacy. These products are often seen as a gentler and more natural alternative to conventional medications. As a result, there is a growing number of homeopathic products available in the market, ranging from cough syrups to nasal sprays.Another trend in the market is the growing demand for combination products. Customers in France prefer to purchase cold and cough remedies that offer multiple benefits in a single product. For example, they are more likely to choose a cough syrup that also provides relief from congestion and sore throat, rather than buying separate products for each symptom. This trend is driven by convenience and the desire for a holistic approach to symptom relief.

Local special circumstances: One of the special circumstances in the French market is the strong influence of the pharmaceutical industry. France has a well-established pharmaceutical sector, with a large number of domestic and international pharmaceutical companies operating in the country. These companies have a significant presence in the Cold & Cough Remedies market and often have a strong marketing and distribution network. This has led to a wide availability of cold and cough remedies in various forms such as tablets, syrups, and lozenges.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in France is also influenced by macroeconomic factors such as the aging population and increasing healthcare expenditure. France has a rapidly aging population, which is more susceptible to cold and cough symptoms. As a result, there is a growing demand for remedies that can provide relief from these symptoms. Additionally, the government's focus on improving healthcare infrastructure and increasing healthcare expenditure has also contributed to the growth of the market. This has led to increased access to healthcare services and a greater awareness of the importance of managing cold and cough symptoms effectively.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.